04:42 PM EDT, 08/13/2025 (MT Newswires) -- Andrew S Boyer, Executive Vice President, on August 12, 2025, sold 33,436 shares in Amneal Pharmaceuticals ( AMRX ) for $302,596. Following the Form 4 filing with the SEC, Boyer has control over a total of 256,670 Class A common shares of the company, with 256,670 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1723128/000172312825000048/xslF345X05/wk-form4_1755117489.xml